Back to search

National and Kapodistrian University of Athens

Γενετική προδιάθεση μεταβολικού συνδρόμου σε υγιείς μετεμμηνοπαυσιακές γυναίκες και αλληλεπίδραση με την ορμονική θεραπεία

Abstract

dc:description

Introduction: Postmenopausal women have an increased prevalence of the metabolic syndrome and this is attributed to a complex interaction between environmental and genetic factors. The aim of the present study was to investigate the impact of Methylenetetrahydrofolate reductase (ΜΤΗFR) C677T polymorphism and Plasminogen activator inhibitor - 1 polymorphism (PAI-1) 4G/5G on the metabolic syndrome, its separate components and other metabolic indices in postmenopausal women under hormone therapy.Methods: The study population consisted of 160 postmenopausal women and 145 of them received per os 1mg estradiol/2mg drospirenone (N=70) or transdermal 50 mcg estradiol/250 mg norethisterone (N=17) or per os 2.5 mg tibolone (N=27) or 60 mg raloxifene (N=31). The control group consisted of 15 postmenopausal women who did not receive any treatment regarding menopause. Multiplex polymerase chain reaction (PCR) was used to assess the presence of the two polymorphisms. One year later the participants were re-examined regarding the presence of the metabolic syndrome, its components and changes in other metabolic assays in the several subgroups formed based on the administered hormone therapy and the presence of the examined polymorphisms.Results: In the subgroup of women who received per os estradiol/drospirenone the TT genotype correlated with an increase in total and LDL cholesterol compared to the other two genotypes in which the same indices were decreased under the same treatment (P=0.032, P=0.002 και P=0.011 respectively). In the same subgroup the 4G/4G genotype was associated with increased systolic blood pressure (P=0.049), lipoprotein a (P=0.024) and insulin (P=0.049) levels compared to the 4G/5G and 5G/5G genotypes. In the transdermal hormone therapy subgroup the presence of the 4G allele led to decreased triglycerides (P=0.025) and increased HDL cholesterol (P=0.010) and apolipoprotein B levels (P=0.004). In the tibolone subgroup postmenopausal women homozygous for the 4G allele emerged a more intense decrease of HDL and apolipoprotein levels (P=0.014, P=0.014 respectively), while they experienced a smaller increase of their diastolic pressure (P=0.027) compared to the other two genotypes. Finally, in the raloxifene subgroup the T allele associated with a greater increase of apolipoprotein B and insulin levels (P=0.044, P=0.028 respectively). In the same subgroup the 4G allele correlated with a relatively smaller increase of glycosylated haemoglobin, a decrease of diastolic blood pressure (P=0.046, P=0.049 respectively) and an increase of the waist to hip ratio compared to the normal genotype ( P=0.015).Conclusions: The MTHFR C677T and PAI-1 4G/5G polymorphisms modified the impact of postmenopausal hormone therapy on the metabolic syndrome components and other metabolic indices. The present study contributes to the elucidation of the genetic component of the metabolic syndrome in postmenopausal women.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Papadimitriou, Dimitra
  • Παπαδημητρίου, Δήμητρα

Subjects

dc:subject × 18

Rights

dc:rights
Statement dc:rights
  • BY_NC_SA
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/42150

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Papadimitriou, Dimitra; Παπαδημητρίου, Δήμητρα. Γενετική προδιάθεση μεταβολικού συνδρόμου σε υγιείς μετεμμηνοπαυσιακές γυναίκες και αλληλεπίδραση με την ορμονική θεραπεία. National and Kapodistrian University of Athens, 2014. http://hdl.handle.net/10442/hedi/42150